Skip to main content
Moderate Aortic Valve StenosisDrugPhase 2, Phase 3

What this study is

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.

What's being tested

  • Ataciguat

    Intervention · DRUG

    Ataciguat will be administrated daily for up to 156 weeks

  • Placebo

    Intervention · DRUG

    Placebo will be administrated daily for up to 156 weeks

Study details

Official title
A Phase 2b/3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants With Moderate Calcific Aortic Valve STenosis
Sponsor
Kardigan, Inc.
Conditions
Moderate Aortic Valve Stenosis
Enrolling
1,276 people
Starts
2025-06-27
Est. completion
2030-09-30
Design
Quadruple-blind, randomized, parallel groups, Phase 2, Phase 3
Record
View on ClinicalTrials.gov ↗